Bayer’s BlueRock Reports the P-I Study Data for Bemdaneprocel (BRT-DA01) Stem Cell Therapy to Treat Parkinson’s Disease
June 29, 2023
Bayer Reports the Initiation of the P-III (QUANTI) Trials for Gadoquatrane as a Contrast Agent for Magnetic Resonance Imaging
June 28, 2023
Bayer to Initiates P-III Study (FINE-ONE) of Finerenone for the Treatment of Chronic Kidney Disease and Type 1 Diabetes
June 22, 2023
Bayer Entered into an Exclusive License Agreement with Cedilla Therapeutics to Develop and Commercialize CyclinE1/CDK2 Complex Inh...
June 2, 2023
Bayer Entered into a Collaboration Agreement with Bicycle Therapeutics for the Development of Novel Targeted Radionuclide Therapie...
May 11, 2023
Bayer’s Kerendia (finerenone) Receives NICE Recommendation for Chronic Kidney Disease Associated with Type 2 Diabetes
March 27, 2023
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.